Work

Phase I/II Dose Expansion Of a Multi-Center Trial Of Carfilzomib and Pomalidomide With Dexamethasone (Car-Pom-d) In Patients With Relapsed/Refractory Multiple Myeloma

Year: 2013

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v122.21.690.690

Authors: Jatin J. Shah, Edward A. Stadtmauer, Rafat Abonour, Adam D. Cohen, William Bensinger, Cristina Gasparetto, Jonathan L. Kaufman, Suzanne Lentzsch, Dan T. Vogl, Robert Z. Orlowski, Erica L. Kim, Natalia Bialas, David D. Smith, Brian GM Durie

Institutions: The University of Texas MD Anderson Cancer Center, University of Pennsylvania, Indiana University Indianapolis, Indiana University School of Medicine, Fox Chase Cancer Center, Fred Hutch Cancer Center, Duke Medical Center, Emory University, Winship Cancer Institute, Columbia University, Abramson Cancer Center, Criterium, Inc. (United States), City Of Hope National Medical Center, City of Hope, Cedars-Sinai Medical Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W9899198

FWCI: 7.894

Cites:

Cited by: 38

Related to: 10